Abstract:Event Abstract Back to Event Endosome-mimicking nanogels for targeted drug delivery Jicheng Yu1, 2, Yuqi Zhang1, 2, Wujin Sun1, 2, Chao Wang1, 2, Davis Ranson1, Yanqi Ye1, 2 and Zhen Gu1, 2, 3 1 University of North Carolina at Chapel Hill and North Carolina State University, Joint Department of Biomedical Engineering, United States 2 University of North Carolina at Chapel Hill, Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School, United States 3 University of North Carolina School of Medicine, Department of Medicine, United States Introduction: Drug delivery systems based on natural particulates, as one of the most promising strategies, have potential for cancer therapy[1]. Taking advantages of biological functions and physical morphologies of natural particulates, these biomimetic drug carriers offer several significant advantages such as selective targeting, prolonged circulation time, and low immunogenicity[2,][3]. Materials and Methods: Here we describe a simple method to prepare an endosome membrane-coated nanogel (EM-NG) from source cancer cells[4]. Following intracellular uptake of methacrylated hyaluronic acid[5]-[7] (m-HA) adsorbed SiO2/Fe3O4 nanoparticles encapsulating crosslinkers and photoiniators, EM-NG was easily formed through in situ polymerization initiated by UV irradiation inside endosome. The endosome containing HA nanogel is readily collected via the magnetic extraction with the help of the entrapped magnetic Fe3O4 nanocrystals. Then, a model anticancer drug Doxorubicin (DOX) was further loaded into EM-NG via dispersion. Results and Discussion: The TEM image showed the EM-NGs were round-oval in shape (Figure 1A), and the average diameter was 262.3 nm. The successful coating of endosome membrane was validated by the western blotting analysis against the early endosome antigen 1. The resulting DOX loaded EM-NG (DOX-EM-NG) was demonstrated to efficiently target the source cancer cells through a specific homotypic affinity. Moreover, DOX-EM-NGs were able to moreefficiently deliver anticancer drug to source cancer cells than the nanogel without endosome membrane(Figure 1B), while there were insignificant differences compared to DOX-NGs when treated toward non-source cancer cells. Figure 1. (A) The TEM image of EM-NG. (Scale bar: 200 nm) (B) In vitro cytotoxicity of EM-NG, free DOX, DOX-NG and DOX-EM-NG towards HeLa cells after incubation for 24 h. *P <0.05. Conclusions: We developed a facile method to prepare endosome membrane-coated nanogels as biomimetic drug carrier. This endosome-mimicking nanogel showed excellent targeting ability to the homotypic cells. This study illustrates the potential of utilizing endosome membrane-mimicking formulation for targeted cancer therapy, and offers guideline for developing bio-inspired drug delivery system. the grant from NC TraCS, NIH’s Clinical and Translational Science Awards (CTSA, NIH grant 1UL1TR001111) at UNC-CHReferences:[1] Mitragotri S, Anderson DG, Chen XY, Chow EK, Ho D, Kabanov AV, Karp JM, Kataoka K, Mirkin CA, Petrosko SH, Shi J, Stevens MM, Sun S, Teoh S, Venkatraman SS, Xia Y, Wang S, Gu Z, Xu C. Accelerating the translation of nanomaterials in biomedicine. ACS Nano 2015;9(7):6644-6654.[2] Hu Q, Qian C, Ye Y, Wang C, Gu Z. Anticancer platelet-mimicking nanovehicles. Advanced Materials 2015, in press.[3] Fang RH, Hu C-MJ, Luk BT, Gao W, Copp JA, Tai Y, O’Connor DE, Zhang L. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano letters 2014;14(4):2181-2188.[4] Yu J, Zhang Y, Sun W, Chao W, Ranson D, Ye Y, Gu Z. Endosome-mimicking nanogels for targeted drug delivery. Journal of Biomedical Materials Research Part B: Applied Biomaterials, submitted.[5] Yu J, Zhang Y, Ye Y, DiSanto R, Sun W, Ranson D, Ligler FS, Buse JB, Gu Z. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Proceedings of the National Academy of Sciences 2015;112(27):8260-8265.[6] Mo R, Jiang T, DiSanto R, Tai W, Gu Z. ATP-triggered anticancer drug delivery. Nature Communications 2014;5.[7] Jiang T, Mo R, Bellotti A, Zhou J, Gu Z. Gel–Liposome‐Mediated Co‐Delivery of Anticancer Membrane‐Associated Proteins and Small‐Molecule Drugs for Enhanced Therapeutic Efficacy. Advanced Functional Materials 2014;24(16):2295-2304. Keywords: Biomimetic, gel, targeting delivery Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016. Presentation Type: Poster Topic: Cell-targeting biomaterials in theranostic delivery Citation: Yu J, Zhang Y, Sun W, Wang C, Ranson D, Ye Y and Gu Z (2016). Endosome-mimicking nanogels for targeted drug delivery. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.01196 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 27 Mar 2016; Published Online: 30 Mar 2016. Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Jicheng Yu Yuqi Zhang Wujin Sun Chao Wang Davis Ranson Yanqi Ye Zhen Gu Google Jicheng Yu Yuqi Zhang Wujin Sun Chao Wang Davis Ranson Yanqi Ye Zhen Gu Google Scholar Jicheng Yu Yuqi Zhang Wujin Sun Chao Wang Davis Ranson Yanqi Ye Zhen Gu PubMed Jicheng Yu Yuqi Zhang Wujin Sun Chao Wang Davis Ranson Yanqi Ye Zhen Gu Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.

Correction to Intracellular Fate of Nanoparticles with Polydopamine Surface Engineering and a Novel Strategy for Anti-Exocytosis Enhanced, Lysosome Impairment-Based Cancer Therapy

Correction to “Lactoferrin-Modified Gambogic Acid Liposomes for Colorectal Cancer Treatment”

Correction to Targeting Osteocytes to Attenuate Early Breast Cancer Bone Metastasis by Theranostic Upconversion Nanoparticles with Responsive Plumbagin Release

Correction to “renal Clearable Bi–Bi2S3 Heterostructure Nanoparticles for Targeting Cancer Theranostics”

Intracellular Fate of Nanoparticles with Polydopamine Surface Engineering and a Novel Strategy for Anti-Exocytosis Enhanced, Lysosome Impairment-Based Cancer Therapy (vol 17, pg 6790, 2017)

Correction to “hyaluronan Reduces Cationic Liposome-Induced Toxicity and Enhances the Antitumor Effect of Targeted Gene Delivery in Mice”

Correction to “intestinal Mucin Induces More Endocytosis but Less Transcytosis of Nanoparticles Across Enterocytes by Triggering Nanoclustering and Strengthening the Retrograde Pathway”

Correction to “Single-Molecular Near-Infrared-II Theranostic Systems: Ultrastable Aggregation-Induced Emission Nanoparticles for Long-Term Tracing and Efficient Photothermal Therapy”

Correction to “A Co-Doped Fe3O4 Nanozyme Shows Enhanced Reactive Oxygen and Nitrogen Species Scavenging Activity and Ameliorates the Deleterious Effects of Ischemic Stroke”

Correction to “identification of Tumor Specific Peptide As EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application”

Correction to Cisplatin-Cross-Linked and Oxygen-Resupply Hyaluronic Acid-Based Nanocarriers for Chemo-photodynamic Therapy

Correction to Near-Infrared-Activated Upconversion Nanoprobes for Sensitive Endogenous Zn2+ Detection and Selective On-Demand Photodynamic Therapy

Correction to "Enhancing the Efficacy and Safety of Doxorubicin against Hepatocellular Carcinoma through a Modular Assembly Approach: The Combination of Polymeric Prodrug Design, Nanoparticle Encapsulation, and Cancer Cell-Specific Drug Targeting"

Correction to “Manipulating Cation−π Interactions with Genetically Encoded Tryptophan Derivatives”

Correction to “design, Synthesis, and Bioactivity Evaluation of Dual-Target Inhibitors of Tubulin and Src Kinase Guided by Crystal Structure”

Retraction of “breast Cancer Chemo-immunotherapy Through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway”

Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors Via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance

Endosome-mimicking Nanogels for Targeted Drug Delivery

A Nanotheranostic System Combining Lysosomal Cell Death and Nuclear Apoptosis Functions for Synergistic Cancer Therapy and Addressing Drug Resistance

Correction To: POD Nanozyme optimized by charge separation engineering for light/pH activated bacteria catalytic/photodynamic therapy